Abstract:Reactive Oxygen Species (ROS)‐regulating nanomedicines for disease treatments mainly include ROS‐upregulating nanomedicines and ROS‐downregulating nanomedicines. Here, ROS‐upregulating nanomedicines can exert the toxic effect by employing nanoplatforms to enhance ROS generation in pathological sites for ROS‐induced toxic therapy, and ROS‐downregulating nanomedicines can scavenge excess ROS to maintain normal physiological process and avoid oxidative stress injuries for antioxidant therapy.Reactive oxygen species (ROS) play an essential role in physiological and pathological processes. Studies on the regulation of ROS for disease treatments have caused wide concern, mainly involving the topics in ROS‐regulating therapy such as antioxidant therapy triggered by ROS scavengers and ROS‐induced toxic therapy mediated by ROS‐elevation agents. Benefiting from the remarkable advances of nanotechnology, a large number of nanomaterials with the ROS‐regulating ability are developed to seek new and effective ROS‐related nanotherapeutic modalities or nanomedicines. Although considerable achievements have been made in ROS‐based nanomedicines for disease treatments, some fundamental but key questions such as the rational design principle for ROS‐related nanomaterials are held in low regard. Here, the design principle can serve as the initial framework for scientists and technicians to design and optimize the ROS‐regulating nanomedicines, thereby minimizing the gap of nanomedicines for biomedical application during the design stage. Herein, an overview of the current progress of ROS‐associated nanomedicines in disease treatments is summarized. And then, by particularly addressing these known strategies in ROS‐associated therapy, several fundamental and key principles for the design of ROS‐associated nanomedicines are presented. Finally, future perspectives are also discussed in depth for the development of ROS‐associated nanomedicines.

Promoting Reactive Oxygen Species Generation: a Key Strategy in Nanosensitizer-Mediated Radiotherapy

Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy

Reactive oxygen species-upregulating nanomedicines towards enhanced cancer therapy

The Integration of Reactive Oxygen Species Generation and Prodrug Activation for Cancer Therapy

Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies

Emerging Strategies of Nanomaterial‐Mediated Tumor Radiosensitization

Nanomaterials for Tumor Hypoxia Relief to Improve the Efficacy of ROS-Generated Cancer Therapy

Nanoparticles (Nps)-Mediated Targeted Regulation of Redox Homeostasis for Effective Cancer Therapy

Reactive Oxygen Species Amplifier for Apoptosis-Ferroptosis Mediated High-Efficiency Radiosensitization of Tumors

Mechanisms of Reactive Oxygen Species Generated by Inorganic Nanomaterials for Cancer Therapeutics

Reactive Oxygen Species (ROS)-Based Nanomedicine.

Chemical Mechanisms of Nanoparticle Radiosensitization and Radioprotection: A Review of Structure-Function Relationships Influencing Reactive Oxygen Species

Engineering nanosystems for ROS-bridged cancer cascade therapy

Reactive Oxygen Species‐Regulating Strategies Based on Nanomaterials for Disease Treatment

Modulating Intracellular Oxidative Stress Via Engineered Nanotherapeutics

Redox regulation and its emerging roles in cancer treatment

Long‐Lasting Reactive Oxygen Species Generation by Porous Redox Mediator‐Potentiated Nanoreactor for Effective Tumor Therapy

Regulation of Redox Balance Using a Biocompatible Nanoplatform Enhances Phototherapy Efficacy and Suppresses Tumor Metastasis

Stimuli‐Responsive Nanoradiosensitizers for Enhanced Cancer Radiotherapy

A Mitochondria-Targeted Nanoradiosensitizer Activating Reactive Oxygen Species Burst for Enhanced Radiation Therapy.

Induction of Reactive Oxygen Species: an Emerging Approach for Cancer Therapy